Subjects with MetS had a significantly greater TG/HDL ratio and IL-6 concentrations than those without MetS, both at initial and annual assessment (p < 0.01), while a significant reduction in both parameters was observed following the implementation of the lifestyle intervention program for one year (Table 3; Figure 2). This evidence concerns the gene IL6 and metabolic syndrome.